• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ROS 响应型纳米医学:靶向乳腺肿瘤微环境。

ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment.

机构信息

Cancer Biology Lab, Department of Biochemistry and Bioinformatics, Institute of Science, GITAM (Deemed to be University), Visakhapatnam, 530045, India.

King Fahd Medical Research Center, King Abdulaziz University, P. O. Box 80216, Jeddah 21589, Saudi Arabia.

出版信息

Curr Med Chem. 2021;28(28):5674-5698. doi: 10.2174/0929867328666201209100659.

DOI:10.2174/0929867328666201209100659
PMID:33297907
Abstract

The breast tumor microenvironment (TME) promotes drug resistance through an elaborated interaction of TME components mediated by reactive oxygen species (ROS). Although there is massive accumulation of data concerning the targeting of the ROS, little is known about the ROS-responsive nanomedicine for targeting breast TME. This review submits the ROS landscape in breast TME, including ROS biology, ROS mediated carcinogenesis, and reprogramming of stromal and immune cells of TME. We also discussed ROS-based precision strategies for imaging TME, including molecular imaging techniques with advanced probes, multiplexed methods, and multi-omic profiling strategies. ROS-responsive nanomedicine also describes various therapies, such as chemo- dynamic, photodynamic, photothermal, sono-dynamic, immune, and gene therapy for BC. We expound ROS-responsive primary delivery systems for chemotherapeutics, phytochemicals, and immunotherapeutics. This review also presents recent updates on nanotheranostics for simultaneous diagnosis and treatment of BCs. We assume that a review on this advancing field will be beneficial to the development of ROS-based nano-theranostics for BC.

摘要

乳腺肿瘤微环境(TME)通过活性氧物质(ROS)介导的 TME 成分的精细相互作用促进耐药性。尽管有大量关于 ROS 靶向治疗的数据积累,但对于针对乳腺 TME 的 ROS 响应性纳米医学知之甚少。本综述介绍了乳腺 TME 中的 ROS 情况,包括 ROS 生物学、ROS 介导的癌变以及 TME 中基质和免疫细胞的重编程。我们还讨论了基于 ROS 的 TME 成像的精准策略,包括具有先进探针的分子成像技术、多重方法和多组学分析策略。ROS 响应性纳米医学还描述了各种治疗方法,如化疗动力学、光动力、光热、声动力、免疫和基因治疗 BC。我们阐述了针对化疗药物、植物化学物质和免疫治疗药物的 ROS 响应性初级递送系统。本综述还介绍了用于 BC 同时诊断和治疗的纳米治疗学的最新进展。我们假设对这一不断发展的领域的综述将有助于开发基于 ROS 的 BC 纳米治疗学。

相似文献

1
ROS-Responsive Nanomedicine: Towards Targeting the Breast Tumor Microenvironment.ROS 响应型纳米医学:靶向乳腺肿瘤微环境。
Curr Med Chem. 2021;28(28):5674-5698. doi: 10.2174/0929867328666201209100659.
2
Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment.活性氧(ROS):在乳腺肿瘤微环境中的关键作用。
Crit Rev Oncol Hematol. 2021 Apr;160:103285. doi: 10.1016/j.critrevonc.2021.103285. Epub 2021 Mar 11.
3
Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.通过将过氧化钙负载到肿瘤微环境响应性纳米颗粒中实现疗效可控的纳米医学,用于前列腺癌的抗肿瘤治疗。
Theranostics. 2020 Aug 2;10(21):9808-9829. doi: 10.7150/thno.43631. eCollection 2020.
4
Recent advances of redox-responsive nanoplatforms for tumor theranostics.用于肿瘤诊疗的氧化还原响应型纳米平台的最新进展。
J Control Release. 2021 Apr 10;332:269-284. doi: 10.1016/j.jconrel.2021.02.030. Epub 2021 Mar 1.
5
Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment.肿瘤微环境响应型动态无机纳米组装体用于癌症成像与治疗。
Adv Drug Deliv Rev. 2021 Dec;179:114004. doi: 10.1016/j.addr.2021.114004. Epub 2021 Oct 15.
6
Nanomedicine-based strategies to target and modulate the tumor microenvironment.基于纳米医学的策略靶向和调节肿瘤微环境。
Trends Cancer. 2021 Sep;7(9):847-862. doi: 10.1016/j.trecan.2021.05.001. Epub 2021 Jun 3.
7
Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple-negative breast cancer.纳米颗粒药物传递系统对肿瘤微环境的响应:在三阴性乳腺癌治疗中的有前途的选择。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Mar-Apr;16(2):e1950. doi: 10.1002/wnan.1950.
8
Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging.基于金立方-立方氧纳米发电机的治疗诊断纳米平台:用于调节肿瘤微环境的精准化疗-光疗和多模态成像。
ACS Nano. 2019 May 28;13(5):5306-5325. doi: 10.1021/acsnano.8b09786. Epub 2019 Apr 29.
9
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.针对肿瘤免疫和基质微环境的策略及其临床相关性。
Adv Drug Deliv Rev. 2022 Apr;183:114137. doi: 10.1016/j.addr.2022.114137. Epub 2022 Feb 7.
10
Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.联合癌症治疗——攻克肿瘤微环境的复杂性。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Sep;13(5):e1704. doi: 10.1002/wnan.1704. Epub 2021 Feb 9.

引用本文的文献

1
Quercetin as a multi-targeted therapeutic agent in breast cancer: molecular targets and therapeutic potential.槲皮素作为乳腺癌的多靶点治疗药物:分子靶点与治疗潜力
Med Oncol. 2025 Jul 22;42(8):365. doi: 10.1007/s12032-025-02907-x.
2
Metabolic reprogramming in cancer and senescence.癌症与衰老中的代谢重编程。
MedComm (2020). 2025 Mar 4;6(3):e70055. doi: 10.1002/mco2.70055. eCollection 2025 Mar.
3
Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy.利用生物材料靶向肿瘤微环境以提高免疫治疗效果。
J Nanobiotechnology. 2024 Nov 27;22(1):737. doi: 10.1186/s12951-024-03005-2.
4
A bibliometric analysis of drug resistance in immunotherapy for breast cancer: trends, themes, and research focus.乳腺癌免疫治疗药物耐药性的文献计量分析:趋势、主题和研究重点。
Front Immunol. 2024 Aug 12;15:1452303. doi: 10.3389/fimmu.2024.1452303. eCollection 2024.
5
Nrf2 mediates the effects of shionone on silica-induced pulmonary fibrosis.Nrf2介导紫菀酮对二氧化硅诱导的肺纤维化的影响。
Chin Med. 2024 Jun 19;19(1):88. doi: 10.1186/s13020-024-00947-5.
6
Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors.纳米平台介导的自噬调控及其在耐药肿瘤联合治疗中的应用
Int J Nanomedicine. 2024 Jan 26;19:917-944. doi: 10.2147/IJN.S445578. eCollection 2024.